Literature DB >> 15222013

Birth characteristics and hepatoblastoma risk in young children.

Giuseppe Latini, Francesco Gallo, Claudio De Felice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15222013     DOI： 10.1002/cncr.20357

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens.

Authors:  Takashi Kobayashi; Masayuki Kubota; Yoshiaki Kinoshita; Yuki Arai; Toshiyuki Oyama; Naoki Yokota; Koichi Saito; Yasunobu Matsuda; Mami Osawa
Journal:  Pediatr Surg Int       Date:  2019-09-26       Impact factor: 1.827

2.  What do we know about the etiology of hepatoblastoma?

Authors:  Lucie M Turcotte; Logan G Spector
Journal:  Hepat Oncol       Date:  2013-12-20

3.  Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group.

Authors:  Lucie M Turcotte; Michael K Georgieff; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Nicole Miller; Rachel Fonstad; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2014-07-15       Impact factor: 3.167

4.  Maternal Preeclampsia and Odds of Childhood Cancers in Offspring: A California Statewide Case-Control Study.

Authors:  Xiaoqing Xu; Beate Ritz; Myles Cockburn; Christina Lombardi; Julia E Heck
Journal:  Paediatr Perinat Epidemiol       Date:  2017-01-26       Impact factor: 3.980

5.  Hepatoblastoma in childhood, long term survival achieved: 2 case reports and literature review.

Authors:  Antoine El Asmar; Ziad El Rassi
Journal:  Int J Surg Case Rep       Date:  2016-02-21

6.  Cancer risk in children and young adults born preterm: A systematic review and meta-analysis.

Authors:  Katryn Paquette; Hallie Coltin; Ariane Boivin; Devendra Amre; Anne-Monique Nuyt; Thuy Mai Luu
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.